SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-23-000003
Filing Date
2023-01-10
Accepted
2023-01-10 14:18:33
Documents
15
Period of Report
2023-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20230109.htm   iXBRL 8-K 35070
2 EX-99.1 a991pressreleaseforjpmconf.htm EX-99.1 19116
3 nvta-20230109_g1.jpg GRAPHIC 36208
4 invitaelogoa02.jpg GRAPHIC 36208
  Complete submission text file 0001501134-23-000003.txt   337405

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20230109.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20230109_lab.xml EX-101.LAB 23924
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20230109_pre.xml EX-101.PRE 12598
9 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20230109_htm.xml XML 11045
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 23520784
SIC: 8071 Services-Medical Laboratories